Manuales, Vilma B.

HRN: 21-47-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/23/2022
08/29/2022
IV
750mg
Q25hrs
CAP-HR/HAP
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: